Contract 75H71225F28020
Cepheid · Department Of Health And Human Services · October 25, 2024
Cepheid was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on October 25, 2024 for $401,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Sunnyvale, CA. This is a task or delivery order issued under parent IDIQ 75H71223A00001. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 14, 2025.
Contract details
- PIID
- 75H71225F28020
- Parent IDIQ
- 75H71223A00001
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Sunnyvale, CA
- First action
- October 25, 2024
- Latest action
- March 14, 2025
Description
CEPHEID, U&O
Modification timeline
-
March 14, 2025Base award$175.0K
-
December 10, 2024Base awardRQI, WRSU$75.7K
-
October 25, 2024Base awardTHE PURPOSE OF THIS BPA CALL IS TO PROVIDE MEDICAL CODING, DATA ENTRY, AND AUDITING FOR PHOENIX INDIAN HEALTH SERVICE.$150.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71225F28020?
Contract 75H71225F28020 is a federal contract awarded to Cepheid by Department Of Health And Human Services on October 25, 2024 for $401,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75H71225F28020?
Cepheid won contract 75H71225F28020 from Department Of Health And Human Services.
How much is contract 75H71225F28020 worth?
Contract 75H71225F28020 has obligated $401,000 to date.